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Abstract
Purpose The Rheumatoid Arthritis Impact of Disease (RAID) score assesses seven impact domains of interest for people 
with RA. This study aimed to test patients’ understanding of the Portuguese RAID and evaluate its cross-cultural validity 
for use in Portugal.
Methods This was a mixed methods study comprising two phases: (i) cognitive debriefing to determine patient’s comprehen-
sion of the Portuguese RAID and (ii) cross-cultural validation using Rasch analysis. Construct validity was determined by fit 
to the model, invariance culture (compared with France and UK datasets) and evidence of convergent and divergent validity.
Results Patients’ input (n = 38) led to minor changes in the phrasing of two items to ensure conceptual equivalence between 
the Portuguese and the original RAID. In Rasch analysis (n = 288), two items ‘Sleep’ and ‘Physical well-being’ in the 
Portuguese dataset did not adequately fit the model specifications, suggesting multidimensionality (sleep—not necessarily 
associated with RA) and redundancy (physical well-being overlapping with functional disability). Despite the imperfections, 
the scale had high internal consistency, evidence of convergent and divergent validity and invariance to culture (compared 
to France n = 195 and UK n = 205 datasets). The scale was well targeted for patients with different levels of disease impact.
Conclusions The RAID has been successfully adapted into Portuguese and it can be used with confidence in clinical prac-
tice. Further research will be required to ensure it captures the full range of sleep problems in RA. Meanwhile, data across 
the three countries (Portugal, France and the UK) are comparable except for the two items (sleep and physical well-being).
Keywords Rheumatoid arthritis · Health-related quality of life · Patient-reported outcome measures · Validation studies · 
Cross-Cultural comparison · Disease impact
Introduction
Rheumatoid arthritis (RA) is the most common and seri-
ous inflammatory arthritis [1]. The clinical presentation 
of RA is not circumscribed to joint inflammation, its main Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s1113 6-018-1959-4) contains 
supplementary material, which is available to authorized users.
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characteristic, but having a systemic involvement. Its symp-
toms such as pain, fatigue, morning joint stiffness, sleep 
disturbances, or depression highly affect patient’s quality of 
life [2, 3]. Because of this, the patient’s perceptions of the 
impact of the disease are of upmost importance.
Different patient-reported outcomes (PROs) have been 
developed to assess the patient’s perspective and are 
included as endpoint for clinical trials [4, 5]. The “Rheu-
matoid Arthritis Impact of Disease” (RAID) score is one of 
these PROs. It was developed in English, through a Euro-
pean League Against Rheumatism (EULAR) initiative, aim-
ing at combining the most important domains for patients 
in one single measure [6, 7]. Several methodological steps 
were followed and are detailed elsewhere [6, 7]. Briefly, the 
first step was to identify important health domains affected 
by RA through a focus group with ten patients from ten 
European countries. These domains were then ranked by 96 
patients based on their personal experiences and the seven 
highest-ranked domains were selected (pain, functional dis-
ability assessment, fatigue, sleep, physical well-being, emo-
tional well-being and coping with disease). The wording and 
the scaling of the domains resulted in seven numerical rating 
scales (NRS), from 0 (best status) to 10 (worst status). The 
relative weights for each domain were then defined based 
on patient priorities (pain weighs 21%, functional disability 
16%, fatigue 15%, and the remaining 12%). Finally, a lon-
gitudinal observational study of 570 patients from 12 Euro-
pean countries revealed its construct validity, reliability and 
sensitivity to change [6, 7]. Later studies supported these 
psychometric properties and acceptability to patients, who 
also commented on its ease of completion [8–10].
The RAID score has now been used in clinical trials 
[11], registries [8] and also in national audits [12], both as 
a global score and for individualized goal setting in clini-
cal practice, using its seven items individually instead of its 
global weighted score [13–16]. This assumes validity and 
reliability of the global score and of each item of RAID, 
although the latter had not been established until now. The 
number of translations of the RAID (over 70 languages) 
[17] also demonstrates the interest in its use. A Portuguese 
translation for Portugal and for Brazil was performed by a 
specialized company (Mapi Institute) in 2012 [17]. How-
ever, the Portuguese RAID required further input from 
patients in Portugal and robust psychometric evaluation of 
the individual items as well as the global score in order to 
ensure valid measurements at the individual and group lev-
els. In addition, the evidence of measurement comparability 
(psychometric equivalence) between the Portuguese RAID 
and the original RAID score needed to be demonstrated in 
order to allow data-pooling and comparison across coun-
tries. Modern psychometric methods such as Rasch analysis 
allow for detailed evaluation of psychometric properties of a 
scale, thus validating the adapted version, as well as testing 
measurement comparability across scales [18]. The aim of 
this study was therefore to test patients’ understanding of 
the Portuguese RAID and evaluate its cross-cultural validity 
using Rasch analysis.
Participants and methods
Study design
This was a mixed methods study comprising two phases: (1) 
cognitive debriefing [19] with patients to assess face validity 
of the existing Portuguese version of RAID and (2) cross-
cultural validation of the Portuguese RAID to assess its 
construct validity, reliability and cross-cultural invariance.
Participants
Consecutive adults with a definite diagnosis of RA [20, 21] 
attending a rheumatology outpatient department in Portu-
gal were included. Patients were excluded only if they were 
unable to respond to the questionnaires unaided.
In parallel, anonymized datasets of patients with RA from 
the UK and France [22] were used to test the RAID’s cross-
cultural invariance.
Data collection
In Phase 1 (Cognitive debriefing), Portuguese patients with 
diverse demographic and clinical characteristics were invited 
to individual interviews or focus groups (with 3–4 patients). 
The previously translated Portuguese RAID was used; this 
score is freely available and not copyrighted [17]. Patients 
were firstly asked to complete the Portuguese RAID unaided; 
then they were asked to assess possible difficulties and to 
probe what they thought was meant by each domain with 
questions such as “What do you think this item means? What 
did you think or consider before giving a number/answer 
to it?”. All interviews were conducted, audio-recorded and 
transcribed verbatim by same researcher (RF).
In Phase 2 (validation study), a consecutive sample of 
patients completed a questionnaire that included the RAID, 
demographic data (gender, age, educational background), 
self-reported disease duration and other PROs to enable test-
ing the RAID’s convergent and divergent validity: Health 
Assessment Questionnaire Disability Index (HAQ-DI) [23], 
Functional Assessment of Chronic Illness Therapy-Fatigue 
(FACIT) [24], patient global assessment (PGA) of disease 
activity (0–100 mm visual analogue scale (VAS)) [25], Hos-
pital Anxiety and Depression Scale (HADS) [26], quality of 
life (EQ-5D) [27], Subjective Happiness Scale (SHS) [28], 
and Ten-Item Personality Inventory (TIPI) [29]. Physician 
global assessment (PhGA) of disease activity (0–100 mm 
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VAS) and treatment were retrieved from medical records. 
Patients were considered as experienced on NRS if they had 
responded to a scale with NRS format in rheumatology more 
than once in the last year, otherwise, they were considered 
not experienced.
Data analysis
Qualitative data from phase 1 were analysed using induc-
tive and realistic thematic analysis according to Braun and 
Clarke [30] guidelines and managed using ATLAS.ti 8, Ber-
lin: Scientific Software Development GmbH. Two authors 
(RF, CD) independently analysed all the transcripts. Team 
discussions showed that they reached similar conclusions.
In phase 2 of this study, Rasch analysis was used to test 
whether the Portuguese RAID had retained its psychomet-
ric properties following the adaptation process. The Rasch 
model provides a mathematical framework against which 
data from questionnaires can be formally assessed to deter-
mine how they conform to propreties  of fundamental meas-
urement [31]. Fit to the model implies construct validity, 
reliability, unidimensionality and statistical sufficiency of 
the total score from the scale. Consequently, interval esti-
mates can be derived from the scale for use in parametric 
analyses [32, 33].
The raw scores of each of the seven RAID items were 
used in all analyses, not the weighted scores. For Rasch 
analysis, RUMM2030 software (Perth, WA: RUMM Labo-
ratory Pty Ltd) was used with Master’s Partial Credit Model 
parameterization [34]. The software uses pairwise condi-
tional maximum likelihood for estimating item parameters. 
Model fit is tested by Chi-square-based fit statistics com-
paring the difference between observed responses and the 
expected values using standardized residuals (null hypoth-
esis being no significant difference between the observed 
and the values expected by the model). Fit to the model is 
supported by (i) item-person interaction statistics, expressed 
as a Z score with a mean of zero (range − 2.5 to 2.5) and 
standard deviation (SD) of one and (ii) non-significant Chi-
square probability. Additionally, an important aspect of 
measurement, the invariance of the tool to different levels 
of the construct being measured, is tested by (iii) item-trait 
Chi-square interaction statistic with a non-significant prob-
ability indicating the invariance of the tool, in this case, the 
invariance of the RAID to different levels of RA impact. A 
more detailed description of the Rasch analysis approach, its 
use in rheumatology and the interpretation of fit statistics is 
given elsewhere [31] .
In addition to the fit statistics, three further tests were con-
ducted within the framework of Rasch analysis, to assess the 
properties of the RAID. These are threshold ordering, unidi-
mensionality and invariance of the scale to culture. Each RAID 
item has 11 response categories, which reflect an ordered 
continuum of higher impact of the domain (from 0 to 10). 
The ‘threshold’ is the point between two adjacent categories, 
where either response is equally probable [35]. When data fit 
the Rasch model, thresholds should be correctly ordered and 
this is tested statistically and presented graphically. Disordered 
thresholds mean that participants have difficulty to consist-
ently discriminate between response categories [31]. Although 
fit to the model implies that the scale is unidimensional, the 
principal component analysis and t test-based method, first 
proposed by Smith [36], were used as a unidimesionality con-
firmatory test. For this test, first two sets of items hypothesized 
to represent low levels and high levels of the trait/construct 
(disease impact) are defined based on the correlation between 
items and the first residual factor, then an independent t test 
is used to compare the difference in these estimates for each 
person. Unidimensionality is confirmed if ≤ 5% of the t tests 
are significant or if lower bound of a binomial 95% CI of the 
observed proportion overlap 5% [36]. Differential item func-
tioning (DIF) analysis within RUMM2030 software is based 
on a two-way analysis of variance (ANOVA) of residuals 
across each level of person factor (age group, gender, educa-
tion background, disease duration, culture) and across different 
levels of trait (disease impact). The presence of uniform DIF 
is suggested if the p value of the main effects (person factor 
e.g. age, culture) is significant. If the p value of the interaction 
effect (person factor X level of trait) is significant, this sug-
gests a non-uniform DIF [37]. The absence of DIF by country 
implies cross-cultural invariance [22].
To assess the convergent and divergent validity, Pearson’s 
correlation coefficients between the RAID items and the other 
measures were calculated and interpreted as good, |r ≥ 0.60|; 
moderate, |r = 0.40–0.59| and poor |r < 0.40| correlation [38]. 
The hypotheses tested were that individual items of the RAID 
score would have (i) good correlation with corresponding 
measures of physical function, fatigue and psychological 
distress (i.e. RAID items 2 and 5 with HAQ-DI, RAID item 
3 with FACIT, and RAID items 6 with HADS) as well as 
good correlations of all RAID items and global measures such 
as health-related quality of life (EQ-5D) and patient global 
assessment (PGA) of disease activity; and (ii) poor correla-
tion with measures of unrelated constructs such as happiness 
(SHS), personality traits (TIPI) and physician global assess-
ment (PhGA).
A p value of 0.05 was considered significant except where a 
Bonferroni adjustment was applied to account for multiple test-
ing i.e. 0.05/number of tests. Missing data were not imputed. 
Analyses were conducted using IBM® SPSS® Version 20.0. 
Armonk, NY: IBM Corp. and RUMM2030 software, Perth, 
WA: RUMM Laboratory Pty Ltd.
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Results
Patient characteristics
In total, 38 patients were included in Phase 1 and 288 in 
Phase 2. Their demographic and clinical characteristics are 
summarized in Table 1. Most patients were women, with 
low education background and with long standing disease 
duration.
Phase 1: cognitive debriefing
Few issues were raised about understanding of some termi-
nologies used in four items (items 3, 4, 5 and 6); however, 
only two items (item 3 and item 4) were subject to minor 
changes:
Item 3—“Fatigue. Circle the number that best describes 
how much fatigue you felt due to your RA during the last 
week”. Some patients did not know the meaning of “Fadiga” 
(Fatigue); the term “Cansaço” (tiredness) was known by 
everyone:
“I understand what fatigue is but tiredness I would 
have understood better.” (Patient 7)
After discussion, it was agreed to add the second term to 
the head of the item—“Fadiga/Cansaço”.
Item 4—“Sleep: circle the number that best describes the 
sleep difficulties (i.e. resting at night) you felt due to your 
RA during the last week”. In the Portuguese version the term 
“difficulties” was translated into “distúrbios” (disturbances). 
For some patients this term was difficult to understand, as it 
may be understood as “disease/diagnose” or as “difficulty to 
sleep” and the problem could be “sleep too much”:
“Sometimes I sleep bad because of other problems, 
related to me, not related to the pain, thank God. (...) 
Maybe it would be better to use «loss of sleep» or other 
simpler word [instead of disturbances]...” (Patient 5) 
“Maybe «changes», although disturbances is under-
standable...” (Patient 7), “or «difficulties»...” (Patient 
6)
It was agreed to change the term “distúrbios” to “dificul-
dades” (difficulties).
Item 5—“Physical well-being: Considering your arthritis 
overall, how would you rate your level of physical well-
being during the past week?”. For most patients to be in 
a good state of physical well-being (“Bem-estar físico”) 
was described as: not having pain, followed in terms of fre-
quency by being able to walk, and in lesser extent, being able 
to perform domestic/work tasks and few patients referred 
to other meanings. Among patients, the concept mean-
ing appeared to overlap with item 2 (functional disability 
assessment/“Avaliação de deficiência funcional”), which 
assesses the difficulty in doing daily physical activities. The 
researchers considered this as a conceptual problem rather 
than a translation issue. Supplementary Table S1 presents 
patient’s quotes related to the four items.
Beyond the terminologies used in the four items, the 
anchors of the NRS were also discussed because at least two 
patients assumed that ten correspond to better health condi-
tion, disregarding what was written in the NRS’s anchors. 
One patient made an analogy with the grades of a school’s 
test:
“Yes, it is like the grades: 5 is nothing but 10 is already 
a good mark. Because of that people may think that 10 
is good.” (Patient 15).
Since this was a major change, without enough support, 
no changes were done to these anchors.
Phase 2: cross‑cultural validation
FIT to the model
Table 2 presents item fit statistics for each country and for 
the pooled data. Table 3 presents item-person fit statistics, 
person separation reliability and unidimensionality of the 
RAID. Two items (sleep and physical well-being) had fit 
residual values outside the acceptable (− 2.5 to 2.5) range; 
Table 1  Characteristics of patients included in the Portuguese dataset
bDMARD biological disease-modifying antirheumatic drugs, 
DAS28(CRP)4v Disease activity assessment using 28-joint counts, 
C-reactive protein and four variables, HAQ-DI Health Assessment 
Questionnaire Disability Index, na not assessed, NRS Numeric Rating 
Scale, PGA Patient Global Assessment, SD standard deviation
a Missing data in 6 (2.1%) patients
Variable Phase 1 (n = 38) Phase 2 (n = 288)
Gender (female) [n (%)] 32 (84.2) 236 (81.9)
Age [years, mean (SD)] 58.6 (10.4) 59.8 (12.4)
Education background [n (%)]
 ≤ 4 years 22 (57.9) 139 (48.3)
 5–9 years 4 (10.5) 66 (22.9)
 10–12 years 7 (18.4) 49 (17.0)
 > 12 years 5 (13.2) 34 (11.8)
Disease duration [years, mean 
(SD)]
15.7 (11.3) 11.8 (8.9)
Treated with bDAMRDS [n 
(%)]
25 (65.8) 87 (30.2)
DAS28(CRP)4v [mean (SD)] na 2.9 (1.0)
Experienced with NRS [n (%)] 26 (68.4) 149 (51.7)
HAQ-DI remission (≤ 0.5) [n 
(%)]a
na 77 (27.3)
 PGA (0–100) [mean (SD)] na 44.5 (26.8)
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Table 2  Item fit statistics for each country dataset and the pooled data
Country RAID Item Location SE Fit  residuala DF X2 p  valueb
A: Fit statistics for the original 7-item structure
 Portugal (n = 288)  Pain − 0.072 0.045 0.622 5 2.506 0.776
 Functional disability − 0.162 0.044 − 1.464 5 2.300 0.806
 Fatigue − 0.188 0.043 0.211 5 2.638 0.756
 Sleep 0.265 0.041 4.218 5 15.840 0.007
 Physical WB − 0.202 0.046 − 4.239 5 14.213 0.014
 Emotional WB 0.058 0.043 − 0.120 5 2.074 0.839
 Coping 0.300 0.043 − 0.154 5 0.931 0.968
 UK (n = 205)  Pain − 0.018 0.049 − 0.456 3 2.245 0.523
 Functional disability 0.041 0.048 − 0.848 3 1.936 0.586
 Fatigue − 0.358 0.049 1.986 3 6.374 0.095
 Sleep 0.074 0.042 2.298 3 2.753 0.431
 Physical WB − 0.138 0.051 − 2.316 3 5.325 0.149
 Emotional WB 0.044 0.047 1.483 3 6.003 0.111
 Coping 0.354 0.049 − 0.583 3 2.295 0.513
 France (n = 195)  Pain 0.071 0.051 0.126 3 0.387 0.943
 Functional disability 0.312 0.051 − 1.856 3 5.280 0.152
 Fatigue − 0.348 0.048 − 0.053 3 1.529 0.676
 Sleep 0.123 0.045 4.030 3 11.879 0.008
 Physical WB − 0.306 0.052 − 1.452 3 3.850 0.278
 Emotional WB − 0.058 0.049 1.280 3 1.032 0.793
 Coping 0.206 0.051 − 0.741 3 1.731 0.630
 Pooled (n = 688)  Pain − 0.022 0.028 − 0.341 9 4.393 0.8837
 Functional disability − 0.003 0.027 − 2.747 9 11.875 0.2205
 Fatigue − 0.274 0.027 1.121 9 9.124 0.4259
 Sleep 0.161 0.024 6.000 9 26.725 0.0016
 Physical WB − 0.193 0.028 − 4.912 9 27.081 0.0014
 Emotional WB 0.032 0.027 1.520 9 10.735 0.2943
 Coping 0.300 0.027 − 1.079 9 4.943 0.8392
 Expected values for perfect fit Within ± 2.5 > 0.0071
B: Fit statistics after combining functional disability and physical well-being—6-item structure
 Portugal (n = 288)  Pain − 0.091 0.043 0.101 233.670 2.779 0.734
 Funct. Dis./Phys.WB − 0.204 0.030 − 3.680 233.670 5.365 0.373
 Fatigue − 0.205 0.042 − 0.263 233.670 2.902 0.715
 Sleep 0.222 0.039 3.552 233.670 10.222 0.069
 –
 Emotional WB 0.027 0.042 − 0.536 233.670 2.768 0.736
 Coping 0.251 0.041 − 0.559 233.670 1.432 0.921
 UK (n = 205)  Pain − 0.024 0.048 − 0.675 162.83 2.529 0.470
 Funct. dis./phys. WB − 0.058 0.033 − 2.770 162.83 1.130 0.770
 Fatigue − 0.341 0.048 1.713 162.83 5.853 0.119
 Sleep 0.064 0.041 1.928 162.83 1.384 0.709
 –
 Emotional WB 0.031 0.046 1.196 162.83 5.467 0.141
 Coping 0.328 0.047 − 0.764 162.83 2.766 0.429
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Sleep fit residual = 4.218, p = 0.007, suggesting that this 
item may be measuring a slightly different dimension and 
Physical well-being fit residual = − 4.239, p = 0.014, sug-
gesting redundancy of this item (corroborates the findings 
of our qualitative study—patient interpretation of physical 
well-being overlapped with functional disability). To test 
the extent to which lack of fit was caused by this redundancy 
an attempt was made to combine the Functional disability 
and Physical well-being items into a testlet to address the 
local dependence (Table 2b). This resulted in better fit sta-
tistics for both items (Functional disability/Physical well-
being fit residuals − 3.680, p = 0.373, and sleep fit residual 
DF Degree of Freedom, WB Well-being, RAID Rheumatoid Arthritis Disease Impact
a Large positive values suggest multidimensionality and large negative values suggests local response dependence (item redundancy)
b Bonferroni adjusted p value for model fit (i.e. 0.05/7 tests = 0.0071 and 005/6 tests = 0.0083); Figures in bold represent values bellow adjusted p 
value threshold, indicating misfit of the item to the model
Table 2  (continued)
Country RAID Item Location SE Fit  residuala DF X2 p  valueb
 France (n = 195)  Pain 0.077 0.050 0.003 153.67 0.410 0.938
 Funct. dis./phys. WB − 0.016 0.035 − 4.556 153.67 6.770 0.080
 Fatigue − 0.327 0.047 − 0.186 153.67 1.412 0.703
 Sleep 0.127 0.044 3.742 153.67 9.773 0.021
 –
 Emotional WB − 0.055 0.048 1.144 153.67 0.837 0.840
 Coping 0.194 0.050 − 0.822 153.67 1.878 0.598
 Pooled (n = 688)  Pain − 0.033 0.027 − 0.812 557.83 5.114 0.824
 Funct. dis./phys.WB − 0.117 0.019 − 6.655 557.83 17.664 0.039
 Fatigue − 0.272 0.026 0.634 557.83 9.237 0.416
 Sleep 0.14 0.024 5.249 557.83 18.287 0.032
 –
 Emotional WB 0.014 0.026 1.005 557.83 9.678 0.377
 Coping 0.268 0.026 − 1.456 557.83 6.057 0.734
 Expected values for perfect fit Within ± 2.5 > 0.0083
Table 3  Summary item-person fit statistics for each country-specific and the pooled datasets
CI confidence interval, DF degrees of freedom, SD standard deviation
a p value > 0.05 for model fit
b PSI Person separation index (internal consistence) value > 0.70 is acceptable for group use and > 0.85 for individual use
c Unidimensionality is supported if ≤ 5% (0.05) of independent t tests are significant or if lower-bound of a binomial 95% CI of the observed pro-
portion overlap 5% (0.05)
Country Item fit residual Person fit 
residual
Item-trait–Chi-square 
interaction
Person separation 
reliability (PSI)b
Proportion of independent 
t tests (binomial 95% CI)c
Mean SD Mean SD Value (DF) p  valuea
A: Item-person fit statistics of the scale in original structure (7 items)
 Portugal (n = 288) − 0.132 2.525 − 0.674 1.601 40.501 (35) 0.240 0.940 0.070 (0.045–0.095)
 UK (n = 205) 0.223 1.718 − 0.441 1.372 40.501 (35) 0.173 0.932 0.085 (0.055–0.115)
 France (n = 195) 0.191 1.989 − 0.712 1.571 25.690 (21) 0.219 0.914 0.090 (0.059–0.121)
 Pooled (n = 688) − 0.063 3.476 − 0.652 1.551 94.876 (63) 0.006 0.932 0.072 (0.056–0.089)
B: Item-person fit statistics of the scale with combined Functional Disability and Physical well-being (6-items)
 Portugal (n = 288) − 0.231 2.303 − 0.660 1.484 25.468 (30) 0.702 0.934 0.063 (0.038–0.088)
 UK (n = 205) 0.105 1.829 − 0.440 1.277 19.130 (18) 0.384 0.927 0.060 (0.030–0.090)
 France (n = 195) − 0.113 2.709 − 0.672 1.431 21.080 (18) 0.275 0.910 0.074 (0.043–0.105)
 Pooled (n = 688) − 0.339 3.882 − 0.632 1.435 66.037 (54) 0.126 0.928 0.067 (0.050–0.083)
Expected values for perfect fit 0 1 0 1 > 0.05 > 0.85b Lower bound CI < 0.05
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3.552, p = 0.069). The item-trait Chi-square probabilities in 
each country data were also non-significant but the item fit 
residual for Portugal dataset remained higher (SD = 2.303) 
than expected (SD = 1) (Table 3b). This suggests that local 
dependency was not the only cause for lack of fit.
Threshold ordering and targeting
The thresholds for all seven items were ordered, suggest-
ing that the proposed NRS response structure was work-
ing as intended (Fig. 1). This is also shown in the category 
probability curves (Fig. 2). The scale was well targeted for 
patients with different severity levels of RA impact (Fig. 3).
Unidimensionality and internal consistency
The reliability of Portuguese RAID was excellent 
(PSI = 0.940) and the strict unidimensionality test revealed 
the proportion of significant t tests to be 0.070 (95% CI 
0.045–0.095), supporting the unidimensionality of the scale 
(Table 3).
Fig. 1  Threshold map for Portuguese RAID. The items are in ranked 
order of difficulty according to Rasch model (n = 288). RAID items 
were answered in a numerical rating scale from 0 to 10, values repre-
sented here as response categories from 1 to 11. It would be expected 
that as the person’s disease impact increases, they would be more 
likely to obtain a higher score and that this would increase systemati-
cally in a logical progression
Fig. 2  Category probability curve for item 1 (Pain) of Portuguese 
RAID (n = 288). The x-axis represents the construct, with the pain 
increasing to the right. The y-axis shows the probability of scoring 
the categories: Each of the 11 categories emerged as the most likely 
to be selected at some point upon the underlying pain scale, showing 
logical progressive order
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Invariance
There was no DIF by country on any of the RAID items; 
therefore, cross-cultural validity of the RAID is supported 
(Table 4). Furthermore, the scale was invariant to age, gen-
der, education background, disease duration and functional 
capacity.
Convergent validity
As hypothesized, the correlation of RAID items with other 
PROs (Table  5) was good (r ≥ 0.60), namely between 
HAQ-DI and “RAID Functional disability” and “RAID 
Physical well-being” (r = 0.66 and r = 0.67, respectively), 
FACIT and “RAID Fatigue” (r = − 0.65) [also good corre-
lations with “RAID Physical well-being” and “RAID emo-
tional well-being”, r = − 0.60 for both], HADS depres-
sion and “RAID emotional well-being” (r = 0.61), and 
between PGA and between EQ-5D with all RAID items, 
except with “RAID sleep” which had moderate correla-
tions (r = 0.57 and r = − 0.52, respectively). The remain-
ing correlations between RAID items and the other PROs 
were moderate (0.40 ≤ r < 0.60), as expected.
Fig. 3  Person-item threshold distribution for the 7 items of the Rheu-
matoid Arthritis Impact of Disease (RAID) score. These graphs pre-
sent the distribution of items: the x-axis is the logit score and repre-
sents the interval scaling of the items according to the Rasch model, 
with − 4 being no impact and 5 being high impact of disease. The 
lower part of each histogram is where individual items are located 
along the scale; the top part of histogram represents the number of 
people and their total RAID logit score. a Represents the pooled anal-
ysis of all patients, showing very good fit between person and items. 
b. Represents the persons divided by the three countries, also with 
very good fit. French patients have more impact of the disease as the 
central part of the distributions goes more into the left than the other 
two countries. In both diagrams the extremes (n = 14) were omitted
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Divergent validity
The correlations of RAID items with PhGA, with happiness 
(SHS) and with Personality traits (TIPI) were, as expected, 
poor (r < 0.40) or not statistically significant (Table 5).
Discussion
This study aimed to incorporate patient perspective in the 
adaptation of the Portuguese RAID, an impact questionnaire 
for RA, and to validate it for use in Portugal using modern 
statistical approaches.
The Portuguese version of the RAID, as well as many 
of its translations to other languages, was carried out by 
Mapi Institute, an organization specialized in PROs research. 
However, the Portuguese RAID required further input from 
a wider group of patients before the statistical evaluation of 
the underlying construct was carried out [19]. Our qualita-
tive study (phase I) added more patients’ perspective into 
the Portuguese RAID, making it more meaningful to them. 
As a result, minor changes were performed in Fatigue and 
Sleep items to ensure that patients understand the concepts 
intended by the items and thus give accurate responses.
The cognitive debriefing also revealed that some patients 
may not read the item anchors which might led them to inter-
pret 10 as good when it means bad. This misunderstanding 
has also been found in other studies regarding VAS inter-
pretation by patients with chronic conditions [39–41]. This 
problem might have been resolved by adding smiley faces at 
the extremes like in pain assessment for children or elderly 
persons, but it would have been a major change to the tool 
Table 4  Cross-cultural DIF of the RAID items by age and by country
WB Well-Being
a Categorized as < 60 years and ≥ 60 years old
b Bonferroni adjusted p value for model fit: 0.05/7 tests = 0.0071
Dataset RAID domain Agea Country
Mean square F (DF) p  valueb Mean square F (DF) p  valueb
Portugal (n = 288) Pain 0.05 0.06 (1) 0.81 Not applicable
Functional disability 0.37 0.49 (1) 0.48
Fatigue 0.01 0.01 (1) 0.93
Sleep 0.45 0.34 (1) 0.56
Physical WB 0.13 0.24 (1) 0.62
Emotional WB 1.90 2.29 (1) 0.13
Coping 2.11 2.55 (1) 0.11
UK (n = 205) Pain 0.50 0.62 (1) 0.43 Not applicable
Functional disability 0.63 0.81 (1) 0.37
Fatigue 1.43 1.32 (1) 0.25
Sleep 0.14 0.12 (1) 0.73
Physical WB 0.12 0.19 (1) 0.66
Emotional WB 0.19 0.19 (1) 0.66
Coping 3.78 4.85 (1) 0.03
France (n = 195) Pain 1.30 1.52 (1) 0.22 Not applicable
Functional disability 3.32 5.53 (1) 0.02
Fatigue 1.40 1.64 (1) 0.20
Sleep 0.00 0.00 (1) 0.96
Physical WB 0.02 0.03 (1) 0.87
Emotional WB 4.70 4.93 (1) 0.03
Coping 0.21 0.28 (1) 0.60
Pooled (n = 688) Pain 0.07 0.09 (1) 0.770 0.90 1.07 (2) 0.343
Functional disability 4.70 6.66 (1) 0.010 2.90 4.21 (2) 0.015
Fatigue 1.64 1.80 (1) 0.180 3.85 4.22 (2) 0.015
Sleep 2.26 1.72 (1) 0.190 1.25 0.98 (2) 0.376
Physical WB 0.02 0.03 (1) 0.966 1.19 0.32 (2) 0.727
Emotional WB 3.15 3.37 (1) 0.067 0.21 0.23 (2) 0.797
Coping 8.35 10.55 (1) 0.001 1.11 1.41 (2) 0.246
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that is already established. Providing a brief explanation 
about the anchors of the scale may therefore be important 
especially for first time users or for those patients with low 
literacy or low educational level [39, 42].
The results of Rasch analysis highlighted two issues (i) 
redundancy of Physical well-being (overlapping with func-
tional disability) and (ii) the possibility that Sleep item 
measures a slightly different dimension. These issues were 
not observed in the UK dataset (the original RAID was 
developed in English) suggesting that the problem may not 
be inherent to RAID itself but reflecting imperfections of 
the cross-cultural adaptations. Addressing the redundancy 
by combining the two locally dependent items (physical 
well-being and functional disability) improved the scale per-
formance, including fit residuals for the sleep item. Future 
developments need to address the phrasing of physical 
well-being to avoid confusion with functional disability. As 
sleep item still displayed higher SD than expected by Rasch 
model, the improvement (seen by combining functional dis-
ability and physical well-being) was not sufficient enough 
to justify changing the RAID structure into a 6-item ques-
tionnaire, although this presented a better fit to the model. 
Dimensionality of the sleep item needs further explora-
tion. Sleep problems include difficulties in initiating sleep, 
maintaining sleep, early awakening and non-restorative sleep 
[43]. Given the broad range of sleep problems, it is possible 
that some patients do not necessarily associate them with 
RA impact: “Sometimes I sleep bad because of other prob-
lems”, a patient said. A qualitative study of the Dutch RAID 
found that sleep was hardly mentioned in the focus groups 
with patients [44]. It may be helpful to investigate whether 
conceptual equivalence issues exist in the Portuguese trans-
lation and/or adding explanation to the item to help patients 
associate sleep problems with RA impact.
Despite lack of adequate fit to the Rasch model, construct 
validity of the Portuguese RAID is supported by (i) high 
internal consistency (PSI > 0.85) suggesting enough reli-
ability for use at the individual level (ii) good targeting for 
patients with different levels of disease impact (iii) good 
correlations (convergent validity) between RAID items 
and other tools measuring the same concepts i.e. HAQ-DI, 
FACIT, HADS, EQ-5D, PGA; and (iv) poor correlations 
(divergent validity) between RAID items and tools measur-
ing different concepts i.e. PhGA, happiness and personality 
traits. The first study to test RAID performance in clini-
cal practice (N = 1086) was conducted in Norway,[8] and 
used weighted RAID global score and showed good cor-
relation with PGA, Rheumatoid Arthritis Disease Activity 
Table 5  Pearson’s correlations between the RAID (transformed scores) and other outcomes in the Portuguese dataset (n = 288) to demonstrate 
criterion-related validity
Values represent: r (p value)
EQ-5D EuroQol-5D, FACIT Functional Assessment of Chronic Illness Therapy-Fatigue, HADS Hospital Anxiety and Depression Scale, HAQ-
DI Health Assessment Questionnaire Disability Index, PGA Patient Global Assessment, PhGA Physician Global Assessment, RAID Rheumatoid 
Arthritis Disease Impact, SHS Subjective Happiness Scale, TIPI Ten Item Personality Inventory, WB Well-Being
a Correlations were categorized as moderate if 0.40 ≤ r < 0.60 [38]
b Correlations were categorized as good if r ≥ 0.60 [38]
Other measures Pain Functional dis-
ability
Fatigue Sleep Physical WB Emotional WB Coping
With expected good correlations (convergent validity)
 HAQ-DI 0.56a (< 0.001) 0.66b (< 0.001) 0.61b (< 0.001) 0.58a (< 0.001) 0.67b (< 0.001) 0.59a (< 0.001) 0.61b (< 0.001)
 FACIT − 0.50a (< 0.001) − 0.51a (< 0.001) − 0.65b (< 0.001) − 0.55a (< 0.001) − 0.60b (< 0.001) − 0.60b (< 0.001) − 0.58a (< 0.001)
 HADS—anxiety 0.42a (< 0.001) 0.45a (< 0.001) 0.51a (< 0.001) 0.49a (< 0.001) 0.51a (< 0.001) 0.54a (< 0.001) 0.50a (< 0.001)
 HADS—depres-
sion
0.47a (< 0.001) 0.53a (< 0.001) 0.54a (< 0.001) 0.50a (< 0.001) 0.55a (< 0.001) 0.61b (< 0.001) 0.59a(< 0.001)
 EQ-5D − 0.61b (< 0.001) − 0.69b (< 0.001) − 0.66b (< 0.001) − 0.52a (< 0.001) − 0.71b (< 0.001) − 0.64b (< 0.001) − 0.62b (< 0.001)
 PGA 0.65b (< 0.001) 0.69b (< 0.001) 0.66b (< 0.001) 0.57a (< 0.001) 0.70b (< 0.001) 0.64b (< 0.001) 0.69b (< 0.001)
Without expected good correlations (divergent validity)
 PhGA 0.18 (0.002) 0.17 (0.004) 0.13 (0.029) 0.11 (0.051) -0.04 (0.527) 0.16 (0.007) 0.12 (0.042)
 SHS − 0.26 (< 0.001) − 0.24 (< 0.001) − 0.32 (< 0.001) − 0.30 (< 0.001) − 0.31 (< 0.001) − 0.38 (< 0.001) − 0.37 (< 0.001)
 TIPI—extraversion − 0.21 (0.001) − 0.23 (< 0.001) − 0.24 (< 0.001) − 0.23 (< 0.001) − 0.22 (< 0.001) − 0.22 (< 0.001) − 0.22 (< 0.001)
 TIPI—agreeable-
ness
0.00 (0.978) − 0.02 (0.724) − 0.51 (0.396) − 0.05 (0.428) − 0.04 (0.527) − 0.09 (0.120) − 0.11 (0.070)
 TIPI—conscien-
tiousness
− 0.00 (0.910) − 0.09 (0.125) − 0.09 (0.129) − 0.11 (0.070) − 0.09 (0.144) − 0.14 (0.020) − 0.11 (0.065)
 TIPI—emotional 
stability
− 0.21 (< 0.001) − 0.27 (< 0.001) − 0.26(< 0.001) − 0.25 (< 0.001) − 0.32 (< 0.001) − 0.32 (< 0.001) − 0.26 (< 0.001)
 TIPI—openness to 
experiences
− 0.11 (0.064) − 0.14 (0.017) − 0.20 (0.001) − 0.09 (0.144) − 0.20 (0.001) − 0.17 (0.004) − 0.21 (< 0.001)
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Index (RADAI), Short-Form (SF)-36 general health, SF-6D 
and EQ-5D (rp was 0.82, 0.82, − 0.66, − 0.77 and − 0.73, 
respectively) [8]. In our study of convergent validity look-
ing at individual RAID items, only the Sleep item showed a 
moderate correlation with global measures of health (PGA 
rp = 57, and EQ5D rp = − 0.52), the rest of items had good 
correlations. Indeed, in the above-mentioned Norwegian 
study [8] the weighted RAID global score also had a moder-
ate correlation (rp = 0.59) with the Sleep Medical Outcome 
Study (MOS) subscale. It should be noted that specific sleep 
measures have been shown to have higher correlations with 
the individual RAID item measuring sleep (rp = 0.73–0.78) 
[45]. Our study did not use specific sleep measures hence 
the modest correlations.
This study has three limitations. First, lack of adequate 
fit to Rasch model observed in the Sleep and Physical Well-
being items in the Portugal datasets meant that we could 
not calibrate a stable interval scale from our data (statisti-
cal sufficiency of the total score and interval-level scaling 
depends on adequate fit to the model) [31]. New datasets will 
therefore need to be tested for fit if an interval-level scale is 
desired. The lack of fit may be related to either un-resolved 
conceptual equivalence issues in the translation (explained 
above) or the restrictive nature of Rasch model. Rasch model 
specifies that all items contributing to the scale have uniform 
discrimination—i.e. all items have parallel item characteris-
tic curves. The model detects even minor variations in items 
discrimination across different levels of RA impact. It would 
be useful in future studies to assess the performance the 
RAID using other item response models (2-parameter logis-
tic or 3-parameter logistic models) which can accommodate 
a degree of variation in item discrimination [46]. However, 
fit to these alternative models imply less precise interval 
scale estimates than those derived from Rasch model. It may 
as well be useful to explore how well the RAID works as 
an ordinal measure of disease impact using non-parametric 
item response models such as Mokken scaling [47]. Second, 
the Portuguese dataset was compared with only two coun-
tries, France and the UK. While our data have demonstrated 
comparability of measures across the three countries, the 
evidence supporting cross-cultural equivalence would have 
been stronger if fit to Rasch model was adequate. We there-
fore downgrade our conclusions to apply to the fitting items 
only (excluding physical well-being and sleep). Further 
research will be required to assess measurement equivalence 
of the Portuguese RAID and other adapted versions data are 
compared. Lastly, it is important to note that all our analy-
ses were based on unweighted RAID scores as completed 
by patients. The RAID scoring involves applying different 
weights to different items to obtain clinically meaningful 
measures [6, 7].
The strengths of this study include the following: the 
recruitment of enough Portuguese patients in both phases, 
with good diversity, including patients who are not used to 
completing NRS. The use of Rasch model in our analysis 
enabled a robust assessment of psychometric properties of 
the RAID including different aspects of construct validity 
and response bias, although this may also mean a highly 
strict criteria for measurement validity above that required 
for clinical use. Availability of datasets from the UK and 
France allowed assessment psychometric equivalence 
between the Portuguese RAID, the original RAID and the 
French version.
Beyond research, this study has important clinical impli-
cations. As RAID is a valid measure of the impact of disease 
in RA, without which many PROs would be required, this 
study provides Portuguese patients with a measure that is 
meaningful to them. It will help clinicians and other health 
professionals assess how RA impacts on patients. Also, the 
RAID has been incorporated into the Portuguese National 
Registry [48] which will help inform the impact of RA at 
the population level and provide data for further research.
In conclusion, cross-cultural adaptation and validation 
of the RAID score into Portuguese for Portugal has been 
achieved using cognitive debriefing and Rasch models. 
Although further research will be required to address issues 
observed in the Sleep and Physical well-being items, the 
Portuguese RAID has enough construct validity and reli-
ability for clinical use at individual patient and group level.
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